BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 12509955)

  • 1. Skin cancer and non-Hodgkin's lymphoma as second malignancies. markers of impaired immune function?
    Hemminki K; Jiang Y; Steineck G
    Eur J Cancer; 2003 Jan; 39(2):223-9. PubMed ID: 12509955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of an association between non-Hodgkin's lymphoma and skin cancer.
    Adami J; Frisch M; Yuen J; Glimelius B; Melbye M
    BMJ; 1995 Jun; 310(6993):1491-5. PubMed ID: 7787593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of invasive cancers following squamous cell skin cancer.
    Levi F; Randimbison L; La Vecchia C; Erler G; Te VC
    Am J Epidemiol; 1997 Nov; 146(9):734-9. PubMed ID: 9366621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers.
    Levi F; Randimbison L; Te VC; La Vecchia C
    Br J Cancer; 1996 Dec; 74(11):1847-50. PubMed ID: 8956805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hodgkin's disease: study of treatment intensities and incidences of second malignancies.
    Rodriguez MA; Fuller LM; Zimmerman SO; Allen PK; Brown BW; Munsell MF; Hagemeister FB; McLaughlin P; Velasquez WS; Swan F
    Ann Oncol; 1993 Feb; 4(2):125-31. PubMed ID: 8448080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of subsequent solid tumors after non-Hodgkin's lymphoma: effect of diagnostic age and time since diagnosis.
    Hemminki K; Lenner P; Sundquist J; Bermejo JL
    J Clin Oncol; 2008 Apr; 26(11):1850-7. PubMed ID: 18347006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.
    Swerdlow AJ; Douglas AJ; Hudson GV; Hudson BV; Bennett MH; MacLennan KA
    BMJ; 1992 May; 304(6835):1137-43. PubMed ID: 1392790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: a search for common mechanisms.
    Dong C; Hemminki K
    Br J Cancer; 2001 Sep; 85(7):997-1005. PubMed ID: 11592772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between malignant melanoma and noncutaneous malignancies.
    Wu YH; Kim GH; Wagner JD; Hood AF; Chuang TY
    Int J Dermatol; 2006 May; 45(5):529-34. PubMed ID: 16700785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second primary cancers in patients with squamous cell carcinoma of the skin: a population-based study in Sweden.
    Wassberg C; Thörn M; Yuen J; Ringborg U; Hakulinen T
    Int J Cancer; 1999 Feb; 80(4):511-5. PubMed ID: 9935149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009.
    van der Leest RJT; Hollestein LM; Liu L; Nijsten T; de Vries E
    J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):382-389. PubMed ID: 28898461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma.
    Brennan P; Scélo G; Hemminki K; Mellemkjaer L; Tracey E; Andersen A; Brewster DH; Pukkala E; McBride ML; Kliewer EV; Tonita JM; Seow A; Pompe-Kirn V; Martos C; Jonasson JG; Colin D; Boffetta P
    Br J Cancer; 2005 Jul; 93(1):159-66. PubMed ID: 15970927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital.
    Swerdlow AJ; Barber JA; Horwich A; Cunningham D; Milan S; Omar RZ
    Br J Cancer; 1997; 75(1):116-23. PubMed ID: 9000608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries.
    Kaldor JM; Day NE; Band P; Choi NW; Clarke EA; Coleman MP; Hakama M; Koch M; Langmark F; Neal FE
    Int J Cancer; 1987 May; 39(5):571-85. PubMed ID: 3570550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sunlight and non-Hodgkin's lymphoma: a population-based cohort study in Sweden.
    Adami J; Gridley G; Nyrén O; Dosemeci M; Linet M; Glimelius B; Ekbom A; Zahm SH
    Int J Cancer; 1999 Mar; 80(5):641-5. PubMed ID: 10048959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of second primary cancers, other than melanoma, in an Italian population-based cohort of cutaneous malignant melanoma patients.
    Crocetti E; Carli P
    Eur J Cancer Prev; 2004 Feb; 13(1):33-7. PubMed ID: 15075786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An association between cutaneous melanoma and non-Hodgkin's lymphoma: pooled analysis of published data with a review.
    Lens MB; Newton-Bishop JA
    Ann Oncol; 2005 Mar; 16(3):460-5. PubMed ID: 15642704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subsequent cancers after in situ and invasive squamous cell carcinoma of the skin.
    Hemminki K; Dong C
    Arch Dermatol; 2000 May; 136(5):647-51. PubMed ID: 10815858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial upper aerodigestive tract cancers: incidence trends, familial clustering and subsequent cancers.
    Li X; Hemminki K
    Oral Oncol; 2003 Apr; 39(3):232-9. PubMed ID: 12618195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.